Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emmessar Biotech & Nutrition has submitted a routine compliance certificate under SEBI's Depositories and Participants Regulations for the April–June 2025 quarter. The certificate, issued by its Registrar and Share Transfer Agent (MUFG Intime India, formerly Link Intime), confirms that all share certificates received for dematerialisation during the quarter were processed and confirmed to the depositories within the required timelines. It also confirms that the physical certificates were mutilated and cancelled, and the depositories' names were updated in the company's register of members. The filing was signed by the Company's Secretary and Compliance Officer, Priyanka Sharma, on 16 July 2025.
This is a standard quarterly regulatory compliance filing with no material business or financial impact. Shareholders do not need to take any action, and the stock price is unlikely to be affected.